Adaptive Biotechnologies Corporation (ADPT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 2.46B |
| Enterprise Value | 2.67B |
| P/E Ratio | -59.2 |
| PEG Ratio | -1.18 |
| Price/Sales Ratio | 12.53 |
| Price/Book Ratio | 26.62 |
| Enterprise/Revenue | 13.31 |
| Enterprise/EBITDA | -256.87 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.21 |
| Operating Margin | -0.12 |
| Return On Assets | -0.1 |
| Return On Equity | -0.33 |
| Revenue | 276.98M |
| Revenue/Share | 1.95 |
| Gross Profit | 205.62M |
| EBITDA | -29.85M |
| Net Income | -59.5M |
| Diluted EPS | -0.39 |
| Total Cash | 344.26M |
| Total Cash/Share | 2.18 |
| Total Debt | 410.5M |
| Total Debt/Equity | 2.87 |
| Current Ratio | 4.79 |
| Book Value Per Share | 0.96 |
| 52-Week Change | 78.8 |
| 52-Week High | 26.87 |
| 52-Week Low | 12 |
| Moving Average 50 Days | 23.65 |
| Moving Average 200 Days | 17.82 |
| Average Volume | 2.8M |
| Shares Outstanding | 160.04M |
| % Held by Institutions | 398.23 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |